缩醛磷脂在阿尔茨海默病中的研究进展
Research progress of plasmalogen in Alzheimer's disease
阿尔茨海默病(Alzheimer's disease,AD)是一种进行性神经退行性疾病,其发病机制复杂,且目前治疗手段有限,亟需新的干预靶点。缩醛磷脂(plasmalogen)作为一种天然甘油磷脂,广泛存在于细胞膜(如髓鞘)和某些食物(如海鲜)中,其不仅具有显著的抗炎与抗氧化活性,还被证实参与记忆改善。越来越多的证据表明,缩醛磷脂的减少与 AD 的发生与发展密切相关。缩醛磷脂能够靶向多种关键机制干预 AD 的病理过程,包括清除 β-淀粉样蛋白(β-amyloid,Aβ)沉积、抑制细胞凋亡、促进神经发生和减少小胶质细胞的过度激活,从而发挥神经保护作用。因此补充缩醛磷脂有望成为一种防治 AD 的新策略。本文旨在总结并探讨缩醛磷脂在 AD 发病机制与治疗干预中的最新研究进展,以期为 AD 进一步研究和治疗提供新的方向。
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with complex pathogenesis and limited current treatment options, urgently requiring new intervention targets. Plasmalogen, a naturally occurring glycerophospholipid, is widely distributed in cell membranes (such as myelin sheaths) and certain foods (such as seafood). Not only do they exhibit significant anti-inflammatory and antioxidant activities, but they have also been demonstrated to participate in memory enhancement. Growing evidence indicates that reduced plasmalogens levels are closely associated with the onset and progression of AD. Plasmalogens can target multiple key mechanisms to intervene in AD pathological processes, including clearing amyloid-β (Aβ) deposits, inhibiting apoptosis, promoting neurogenesis, and reducing excessive activation of microglia, thereby exerting neuroprotective effects. Therefore, supplementing with plasmalogens holds promise as a novel strategy for preventing and treating AD. This article aims to summarize and explore the latest research advances on plasmalogens in AD pathogenesis and therapeutic interventions, with the goal of providing new directions for further AD research and treatment.
| [1] |
Scheltens P, De Strooper B, Kivipelto M, |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Alzheimer's disease facts and figures[J].Alzheimers Dement, 2023, 19(4): 1598-1695. |
| [7] |
|
| [8] |
Honsho M, Yagita Y, Kinoshita N, |
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease[J].Folia Neuropathol, 2009, 47(4): 289-299. |
| [21] |
|
| [22] |
|
| [23] |
Metaxas A, |
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
王刚, 齐金蕾, 刘馨雅, |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
Takekoshi H, Fujishima M, Miyazawa T, |
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
Yamagiwa N, Kobayashi H, Okabayashi H, |
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
Fujino M, Fukuda J, Isogai H, |
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
Meletis CD. Alkyl-acylglycerols and the important clinical ramifications of raising plasmalogens in dementia and Alzheimer's disease[J].Integr Med (Encinitas), 2020, 19(3): 12-16. |
| [65] |
|
| [66] |
|
| [67] |
Brites P, Ferreira AS, da Silva TF, |
| [68] |
|
北京自然科学基金(7254474)
浙江省智能教育技术与应用重点实验室开放研究基金(jykf22001w)
中科院心理所自主部署科研类项目(E4CX0915CX)
/
| 〈 |
|
〉 |